Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

17.07 +0.17 (+1.01%)
Streaming Delayed Price Updated: 12:27 PM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch + Lomb Corporation Common Shares

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13 ↗
Benzinga Sam Bankman-Fried Arrested In The Bahamas 
Via Benzinga
News headline image
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits ↗
More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO). 
Via Benzinga
What 7 Analyst Ratings Have To Say About Bausch & Lomb ↗
 
Via Benzinga
News headline image
Expert Ratings for Bausch & Lomb ↗
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Bausch & Lomb ↗
Analysts have provided the following ratings for Bausch & Lomb (NYSE:BLCO) within the last quarter: 
Via Benzinga
News headline image
What 4 Analyst Ratings Have To Say About Bausch & Lomb ↗
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Expert Ratings for Bausch & Lomb ↗
Within the last quarter, Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings: 
Via Benzinga
News headline image
Expert Ratings for Bausch & Lomb ↗
  Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022 ↗
Upgrades 
Via Benzinga
News headline image
From Corporate Raider To Activist Investor: Here Are Three High-Yielding Stocks Carl Icahn Favors ↗
Formerly known as a "corporate raider," Carl Icahn is the founder and controlling shareholder of Icahn Enterprises, which is a large holding company with well diversified positions. 
Via Benzinga
News headline image
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision ↗
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting. 
Via InvestorPlace
News headline image
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst ↗
 
Via Benzinga
News headline image
Expert Ratings for Bausch & Lomb ↗
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
News headline image
IPO Market Posts Slowest Quarter Since Great Recession ↗
IPOs in the second quarter plunged to the lowest level since the Great Recession in 2009, led by health care and technology. 
Via Investor's Business Daily
News headline image
Bausch Health (BHC) Stock Plunges 50% on Patent News ↗
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled. 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
  On Thursday, 108 companies set new 52-week lows. 
Via Benzinga
News headline image
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday ↗
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan. 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022 ↗
Upgrades 
Via Benzinga
News headline image
7 Ways to Prepare for a Recession: An Investor’s Guide ↗
There are plenty of ways to prepare for a recession. Here are seven ways you can make sure you're ready for whatever comes next. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022 ↗
Upgrades 
Via Benzinga
News headline image
2 Cheap Stocks Trading at “Deal of the Century” Prices ↗
Simple value metrics are provenly bad at generating consistent returns, but that doesn't mean there aren't opportunities to be found. 
Via InvestorPlace
News headline image
Expert Ratings for Bausch & Lomb ↗
Over the past 3 months, 7 analysts have published their opinion on Bausch & Lomb (NYSE:BLCO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
News headline image
3 Value Stocks That Could 2x in a Recession ↗
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus. 
Via InvestorPlace
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022 ↗
Upgrades 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More ↗
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO ↗
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022. 
Via InvestorPlace
News headline image
RBC Capital: What To Expect When Bausch Health Companies Reports Q1 Tomorrow ↗
RBC Capital Markets expects Bausch Health Companies Inc (NYSE: BHC) Q1 FY22 revenue of $2.02 billion (previous $2.04 billion; consensus $2.05 billion) and adjusted EBITDA of $799 million (previous $816... 
Via Benzinga
News headline image
Opening Day: Bausch + Lomb Pops In Public Debut ↗
Shares of Bausch + Lomb rose over 11% to end its first trading day at $20. This was the second biggest IPO of the year. Bausch + Lomb opened at $18.50 after having priced its initial public offering at... 
Via Talk Markets
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.